NBC News' Berkeley Lovelace Jr. reports that some officials in the Food and Drug Administration are grappling with how to ...
The FDA has issued a Class I risk classification for a large number of recalled onions produced by Taylor Farms.
An unnecessary FDA policy is making it nearly impossible for schizophrenics without stable medical care to get clozapine, the ...
Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.
The FDA's Dr. Peter Marks says he hopes to keep his job under a second Trump term, and urges Robert F. Kennedy Jr. to "keep ...
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
Revumenib is now an FDA-approved treatment for adult and pediatric patients with relapsed/refractory KMT2A-rearranged acute ...
The FDA has approved revumenib (Revuforj) for the treatment of adult and pediatric patients aged 1 year and older with ...
The FDA's REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...
The FDA has approved a re-engineered formulation of nilotinib with no mealtime restrictions for adult patients with newly ...